Klaria Pharma Holding Stock Working Capital
KLAR Stock | SEK 0.36 0.02 5.26% |
Klaria Pharma Holding fundamentals help investors to digest information that contributes to Klaria Pharma's financial success or failures. It also enables traders to predict the movement of Klaria Stock. The fundamental analysis module provides a way to measure Klaria Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Klaria Pharma stock.
Klaria |
Klaria Pharma Holding Company Working Capital Analysis
Klaria Pharma's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Klaria Pharma Working Capital | 41 M |
Most of Klaria Pharma's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Klaria Pharma Holding is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Competition |
Based on the company's disclosures, Klaria Pharma Holding has a Working Capital of 41 M. This is 90.37% lower than that of the Healthcare sector and 91.35% lower than that of the Drug Manufacturers - Specialty & Generic industry. The working capital for all Sweden stocks is 97.23% higher than that of the company.
Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
All Next | Launch Module |
Klaria Fundamentals
Return On Equity | -0.88 | |||
Return On Asset | -0.29 | |||
Operating Margin | (9.48) % | |||
Current Valuation | 88.14 M | |||
Shares Outstanding | 63.1 M | |||
Shares Owned By Insiders | 10.73 % | |||
Shares Owned By Institutions | 9.75 % | |||
Price To Earning | (18.43) X | |||
Price To Book | 1.42 X | |||
Price To Sales | 8.00 X | |||
Gross Profit | 5.87 M | |||
EBITDA | (39.41 M) | |||
Net Income | (53.53 M) | |||
Cash And Equivalents | 25.49 M | |||
Cash Per Share | 0.47 X | |||
Total Debt | 1.02 M | |||
Current Ratio | 0.68 X | |||
Book Value Per Share | 0.97 X | |||
Cash Flow From Operations | (24.8 M) | |||
Earnings Per Share | (1.72) X | |||
Beta | 0.39 | |||
Market Capitalization | 39.49 M | |||
Total Asset | 118.31 M | |||
Retained Earnings | (9 M) | |||
Working Capital | 41 M | |||
Current Asset | 44 M | |||
Current Liabilities | 3 M | |||
Z Score | 22.8 | |||
Net Asset | 118.31 M |
About Klaria Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Klaria Pharma Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Klaria Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Klaria Pharma Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Klaria Pharma Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Klaria Stock analysis
When running Klaria Pharma's price analysis, check to measure Klaria Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klaria Pharma is operating at the current time. Most of Klaria Pharma's value examination focuses on studying past and present price action to predict the probability of Klaria Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klaria Pharma's price. Additionally, you may evaluate how the addition of Klaria Pharma to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |